BME100 s2015:Group10 12pmL2: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
 
(16 intermediate revisions by 2 users not shown)
Line 13: Line 13:
{| style="wikitable" width="700px"
{| style="wikitable" width="700px"
|- valign="top"
|- valign="top"
| [[Image:BME103student.jpg|100px|thumb|Name: Joseline Valenzuela Quintero]]  
| [[Image:Joseline.jpg|100px|thumb|Name: Joseline Valenzuela Quintero]]  
| [[Image:BME103student.jpg|100px|thumb|Name: Clayton Nunn]]
| [[Image:BME103student.jpg|100px|thumb|Name: Clayton Nunn]]
| [[Image:BME103student.jpg|100px|thumb|Name: Your name]]
| [[Image:ItaiKreisler.jpg|100px|thumb|Name: Itai Kreisler]]
| [[Image:BME103student.jpg|100px|thumb|Name: Your name]]
| [[Image:BME103student.jpg|100px|thumb|Name: Isaac Clouse]]
| [[Image:BME103student.jpg|100px|thumb|Name: Your name]]
 
|}
|}


=LAB 2 WRITE-UP=
=LAB 2 WRITE-UP=
Line 28: Line 27:
'''Experiment 1''' <br>
'''Experiment 1''' <br>


Human Study         0mg         5mg         10mg         15mg
[[Image:ple.jpg]]
 
          
Mean(pg/ml)         3.834         8.932         61.622         657.941
 
StdDev(pg/ml)    1.523010177 1.593931547 30.11069386 212.9429762
 
Endpoint         10         10         10         10
 
Std Error(pg/ml)        0.481618106 0.504045412 9.521837451 67.33848166
 
 




'''Experiment 2'''<br>
'''Experiment 2'''<br>


Rat Study         0mg      10mg
[[Image:ample.jpg]]
 
Mean(pg/ml)         10.516  11.112
 
StdDev(pg/ml)         2.225551617 7.402885924
 
Endpoint         5        5
 
Std Error(pg/ml)        0.995296941 3.310671231
 




Line 83: Line 64:
SUMMARY
SUMMARY
Groups      Count Sum Average Variance
[[Image: hgfhj.jpg]]
Column 1 10 38.34 3.834 2.31956


Column 2 10 89.32 8.932 2.540617778
Column 3 10 616.22 61.622 906.6538844
Column 4 10 6579.41 657.941 45344.71112
ANOVA
ANOVA
Source of Variation SS         df MS         F         P-value F crit
Source of Variation
 
    SS -                  df        MSF      P-value F     crit


Between Groups         3027016.695 3 1009005.565 87.25360195 1.40083E-16 2.866265551
Between Groups         3027016.695 3 1009005.565 87.25360195 1.40083E-16 2.866265551


Within Groups         416306.0267 36 11564.0563
Within Groups         416306.0267 36 11564.0563

Latest revision as of 23:59, 3 February 2015

BME 100 Spring 2015 Home
People
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Photos
Wiki Editing Help

OUR TEAM

Name: Joseline Valenzuela Quintero
Name: Clayton Nunn
Name: Itai Kreisler
Name: Isaac Clouse

LAB 2 WRITE-UP

Descriptive Statistics

Experiment 1


Experiment 2




Results

Experiment 1

Experiment 2




Analysis

Experiment 1
Human Test Anova: Single Factor


SUMMARY


ANOVA

Source of Variation

   SS	-                   df         MSF       P-value	F      crit

Between Groups 3027016.695 3 1009005.565 87.25360195 1.40083E-16 2.866265551

Within Groups 416306.0267 36 11564.0563


Total 3443322.721 39

_____________________________________________________________________________________________________________

Experiment 2

T-Test(Rats) - 0.867403497 The p-value was much greater than .05, therefore not statistically significantly different.




Summary/Discussion

In experiment number 1, human test subjects were given different dosages of LPS between 0-15mg in increments of 5mg. There were ten human test subjects per group. The results show that there is a significant difference between the Inflammotin protein levels between the test subjects. This was tested by contrasting the t-test between each possible pair of dosage (i.e: 0-5mg, 0-15mg). We also conducted an ANOVA test on the human results and found again that the results had a significant difference between the Inflammotin protein levels.

In experiment number 2, rat test subjects were given two different dosages of LPS, one group of five rats were given 0mg and the other five rats were given 10mg. The results of the t-test showed that there was not a significant difference of inflammotin protein levels between the two groups.

There was a larger sample size in the humans than the rats which could have altered the results. With a greater sample size of rats we could have had a more accurate representation of the effect on rats. Based on both the ANOVA and the t-test we were able to conclude with statistical certainty that humans had a more reliable positive correlation with LPS than the rats.